Cargando…

Evidence base to support using prescribed psychostimulants to treat psychostimulant use disorder is limited

Detalles Bibliográficos
Autores principales:	Bahji, Anees, Danilewitz, Marlon, George, Tony P., Dhaliwal, Arash, Crockford, David N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	CMA Impact Inc. 2023
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610955/ https://www.ncbi.nlm.nih.gov/pubmed/37816523 http://dx.doi.org/10.1503/cmaj.149222-l

Ejemplares similares

Navigating Evidence, Challenges, and Caution in the Treatment of Stimulant Use Disorders
por: Bahji, Anees, et al.
Publicado: (2023)

The authors respond to letters on using prescribed psychostimulants to treat stimulant use disorder
por: Palis, Heather N., et al.
Publicado: (2023)

The Rising Tide of Stimulant-Related Morbidity and Mortality Warrants Evidence-Based Treatment
por: Bahji, Anees, et al.
Publicado: (2022)

Psychostimulants and Movement Disorders
por: Asser, Andres, et al.
Publicado: (2015)

Psychostimulant Drugs and Neuroplasticity
por: Fernandez-Espejo, Emilio, et al.
Publicado: (2011)

The Use of Drosophila to Understand Psychostimulant Responses
por: Philyaw, Travis James, et al.
Publicado: (2022)

Risk of Tics with Psychostimulants for ADHD
por: Millichap, J. Gordon
Publicado: (2015)

Binge eating and psychostimulant addiction
por: Blanco-Gandia, M Carmen, et al.
Publicado: (2021)

Role of Microglia in Psychostimulant Addiction
por: Machado da Silva, Maria Carolina, et al.
Publicado: (2023)

S95. DIFFERENCES IN LIFETIME PATTERNS OF PSYCHOSTIMULANTS AND THEIR IMPACT ON THE PROPORTION OF PATIENTS WITH FIRST-EPISODE PSYCHOSIS ATTRIBUTABLE TO PSYCHOSTIMULANTS USE ACROSS EUROPE
por: Duran-Cutilla, Manuel, et al.
Publicado: (2020)

Attention-deficit hyperactivity disorder and use of psychostimulants among children in Turkey
por: Aras, Sahbal, et al.
Publicado: (2007)

Critical View on the Usage of Ribavirin in Already Existing Psychostimulant-Use Disorder
por: Petković, Branka, et al.
Publicado: (2020)

The Role of Adenosine Receptors in Psychostimulant Addiction
por: Ballesteros-Yáñez, Inmaculada, et al.
Publicado: (2018)

The role of serotoninergic system in psychostimulant effects
por: Taracha, Ewa
Publicado: (2021)

Dysfunction of the Neurovascular Unit by Psychostimulant Drugs
por: Vo, Tam Thuy Lu, et al.
Publicado: (2023)

The Therapeutic Potential of Amphetamine-like Psychostimulants
por: Pires, Bruno, et al.
Publicado: (2023)

Unexpected turn of events: Completing residency in the COVID-19 era
por: Danilewitz, Marlon, et al.
Publicado: (2020)

Intentional Discontinuation of Psychostimulants Used to Treat ADHD in Youth: A Review and Analysis
por: Lohr, W. David, et al.
Publicado: (2021)

Dysregulation of Acetylation Enzymes in Animal Models of Psychostimulant use Disorders: Evolving Stories
por: Cadet, Jean Lud
Publicado: (2016)

Psychostimulant Use Disorder, an Unmet Therapeutic Goal: Can Modafinil Narrow the Gap?
por: Hersey, Melinda, et al.
Publicado: (2021)

Incorporating prescription psychostimulants into the continuum of care for people with stimulant use disorder in Canada
por: Palis, Heather, et al.
Publicado: (2023)

First episode psychosis and the use of psychostimulants - a case report
por: Teixeira, T., et al.
Publicado: (2021)

Psychostimulant prescribing trends in a paediatric population in Ireland: a national cohort study
por: Boland, Fiona, et al.
Publicado: (2015)

Behavioral effects of ketamine and toxic interactions with psychostimulants
por: Hayase, Tamaki, et al.
Publicado: (2006)

Is there potential for the treatment of children with ADHD beyond psychostimulants?
por: Hoekstra, Pieter J.
Publicado: (2011)

The Health Effect of Psychostimulants: A Literature Review
por: Favrod-Coune, Thierry, et al.
Publicado: (2010)

Ghrelin and ghrelin receptor modulation of psychostimulant action
por: Wellman, Paul J., et al.
Publicado: (2013)

The Involvement of Norepinephrine in Behaviors Related to Psychostimulant Addiction
por: Zaniewska, Magdalena, et al.
Publicado: (2015)

Role of nitric oxide in psychostimulant-induced neurotoxicity
por: Bashkatova, Valentina, et al.
Publicado: (2019)

Towards competency-based medical education in addictions psychiatry: a systematic review
por: Bahji, Anees, et al.
Publicado: (2021)

Comment on “I’m Virtually a Psychiatrist: Problems with Telepsychiatry in Training”
por: Danilewitz, Marlon, et al.
Publicado: (2022)

Preclinical Evidence That 5-HT(1B) Receptor Agonists Show Promise as Medications for Psychostimulant Use Disorders
por: Garcia, Raul, et al.
Publicado: (2017)

Role of the ERK pathway in psychostimulant-induced locomotor sensitization
por: Valjent, Emmanuel, et al.
Publicado: (2006)

CART Peptides Regulate Psychostimulants and May be Endogenous Antidepressants
por: M.O, Job, et al.
Publicado: (2011)

Cocaine and amphetamine-like psychostimulants: neurocircuitry and glutamate neuroplasticity
por: Kalivas, Peter W.
Publicado: (2007)

Pedunculopontine arousal system physiology—Effects of psychostimulant abuse
por: Urbano, Francisco J., et al.
Publicado: (2015)

Alcohol Interactions with Psychostimulants: An Overview of Animal and Human Studies
por: Althobaiti, Yusuf S., et al.
Publicado: (2016)

A mechanistic overview of approaches for the treatment of psychostimulant dependence
por: Jensen, Kathrine Louise, et al.
Publicado: (2022)

Interaction of Diamine Oxidase with Psychostimulant Drugs for ADHD Management
por: Tobajas, Yaiza, et al.
Publicado: (2023)

Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a systematic review and meta-analysis
por: Bhatt, Meha, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_s1tfnqte3tnl7d09c7u0j3c4ri